Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals (4) Apply Referrals filter Direct healthcare professional communication (7) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (4) Apply Yes filter

Authorisation status

Authorised (426) Apply Authorised filter Refused (17) Apply Refused filter Withdrawn (54) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Positive (10) Apply Positive filter

Application type

Initial authorisation (6) Apply Initial authorisation filter Post-authorisation (4) Apply Post-authorisation filter

Withdrawal type

Initial authorisation (63) Apply Initial authorisation filter Post-authorisation (3) Apply Post-authorisation filter

Withdrawal date

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (5) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (58) Apply PM: decision on the application for modification of an agreed PIP filter W: decision granting a waiver in all age groups for all conditions or indications (12) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (9) Apply Yes filter

Compliance procedure number

Orphan disease / condition

Orphan decision number

Orphan designation status

Positive (219) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Medicine type

Biosimilar Remove Biosimilar filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Accelerated assessment (113) Apply Accelerated assessment filter Additional monitoring (657) Apply Additional monitoring filter Conditional approval (96) Apply Conditional approval filter Exceptional circumstances (70) Apply Exceptional circumstances filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

869 results

Remove all filtersRemove all filters

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine type Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Biosimilar Remove Biosimilar filter

Medicine Summaries of opinion Remove Summaries of opinion filter Orphan designations Remove Orphan designations filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Withdrawn applications Remove Withdrawn applications filter

Sort by

List item

Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)

sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009, , Revision: 14, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Kalydeco (updated)

ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012, , , Revision: 28, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Memantine Mylan (updated)

memantine hydrochloride, Alzheimer Disease
Date of authorisation: 21/04/2013, , Revision: 7, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Sylvant (updated)

siltuximab, Giant Lymph Node Hyperplasia
Date of authorisation: 22/05/2014, , , Revision: 11, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Nexavar (updated)

sorafenib, Carcinoma, Hepatocellular, Carcinoma, Renal Cell
Date of authorisation: 19/07/2006, , Revision: 29, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V. (updated)

lamivudine, HIV Infections
Date of authorisation: 10/12/2009, , Revision: 15, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord (updated)

Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019, , Revision: 3, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Ziextenzo (updated)

pegfilgrastim, Neutropenia
Date of authorisation: 22/11/2018, , , Revision: 3, Authorised, Last updated: 12/05/2021
List item

Human medicine European public assessment report (EPAR): Deltyba (updated)

Delamanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 27/04/2014,
Date of refusal: 25/07/2013, , , , Revision: 16, Authorised, Last updated: 11/05/2021
List item

Human medicine European public assessment report (EPAR): Ruxience (updated)

rituximab, Leukemia, Lymphocytic, Chronic, B-Cell, Arthritis, Rheumatoid, Microscopic Polyangiitis, Pemphigus
Date of authorisation: 01/04/2020, , , Revision: 3, Authorised, Last updated: 11/05/2021
List item

Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)

pregabalin, Anxiety Disorders, Neuralgia, Epilepsy
Date of authorisation: 19/06/2015, , Revision: 6, Authorised, Last updated: 10/05/2021
List item

Human medicine European public assessment report (EPAR): Kyprolis (updated)

carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015, , , Revision: 19, Authorised, Last updated: 07/05/2021
List item

Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)

lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018, , Revision: 6, Authorised, Last updated: 07/05/2021
List item

Human medicine European public assessment report (EPAR): Ketoconazole HRA (updated)

Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014, , , , Revision: 10, Authorised, Last updated: 07/05/2021
List item

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (updated)

efavirenz, emtricitabine, tenofovir disoproxil maleate, HIV Infections
Date of authorisation: 05/09/2017, , Revision: 10, Authorised, Last updated: 07/05/2021
List item

Human medicine European public assessment report (EPAR): Tegsedi (updated)

inotersen sodium, Amyloidosis
Date of authorisation: 05/07/2018, , , , Revision: 7, Authorised, Last updated: 06/05/2021
List item

Human medicine European public assessment report (EPAR): Kaftrio (updated)

ivacaftor, tezacaftor, elexacaftor, Cystic Fibrosis
Date of authorisation: 21/08/2020, , , Revision: 3, Authorised, Last updated: 06/05/2021
List item

Human medicine European public assessment report (EPAR): Flixabi (updated)

infliximab, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Crohn Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 26/05/2016, , , Revision: 17, Authorised, Last updated: 06/05/2021
List item

Human medicine European public assessment report (EPAR): Bortezomib Hospira (updated)

bortezomib, Multiple Myeloma
Date of authorisation: 22/07/2016, , Revision: 11, Authorised, Last updated: 06/05/2021
List item

Human medicine European public assessment report (EPAR): Daurismo (updated)

Glasdegib maleate, Leukemia, Myeloid, Acute
Date of authorisation: 26/06/2020, , , Revision: 2, Authorised, Last updated: 05/05/2021
List item

Human medicine European public assessment report (EPAR): Translarna (updated)

Ataluren, Muscular Dystrophy, Duchenne
Date of authorisation: 31/07/2014, , , , Revision: 19, Authorised, Last updated: 05/05/2021
List item

Human medicine European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka) (updated)

irbesartan hydrochloride, Hypertension
Date of authorisation: 01/12/2008, , Revision: 13, Authorised, Last updated: 05/05/2021
List item

Human medicine European public assessment report (EPAR): Inhixa (updated)

enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 15/09/2016, , , Revision: 18, Authorised, Last updated: 05/05/2021
List item

Human medicine European public assessment report (EPAR): Aybintio (updated)

bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 19/08/2020, , , Revision: 3, Authorised, Last updated: 05/05/2021
List item

Veterinary medicine European public assessment report (EPAR): Sevohale (previously known as Sevocalm) (updated)

sevoflurane, Dogs, Cats
Date of authorisation: 21/06/2016, , Revision: 5, Authorised, Last updated: 05/05/2021

Load more

869 results

Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)

Human medicine European public assessment report (EPAR): Kalydeco (updated)

Human medicine European public assessment report (EPAR): Memantine Mylan (updated)

Human medicine European public assessment report (EPAR): Sylvant (updated)

Human medicine European public assessment report (EPAR): Nexavar (updated)

Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V. (updated)

Human medicine European public assessment report (EPAR): Arsenic trioxide Accord (updated)

Human medicine European public assessment report (EPAR): Ziextenzo (updated)

Human medicine European public assessment report (EPAR): Deltyba (updated)

Human medicine European public assessment report (EPAR): Ruxience (updated)

Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)

Human medicine European public assessment report (EPAR): Kyprolis (updated)

Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)

Human medicine European public assessment report (EPAR): Ketoconazole HRA (updated)

Human medicine European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan (updated)

Human medicine European public assessment report (EPAR): Tegsedi (updated)

Human medicine European public assessment report (EPAR): Kaftrio (updated)

Human medicine European public assessment report (EPAR): Flixabi (updated)

Human medicine European public assessment report (EPAR): Bortezomib Hospira (updated)

Human medicine European public assessment report (EPAR): Daurismo (updated)

Human medicine European public assessment report (EPAR): Translarna (updated)

Human medicine European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka) (updated)

Human medicine European public assessment report (EPAR): Inhixa (updated)

Human medicine European public assessment report (EPAR): Aybintio (updated)

Veterinary medicine European public assessment report (EPAR): Sevohale (previously known as Sevocalm) (updated)